Park Medi World shareholders approve all six resolutions at 15th AGM
- All six resolutions at Park Medi World's 15th AGM were passed successfully
- Institutional investors opposed ESOP extension to group companies with 80% dissent
- Routine financial adoption and director reappointment passed with near-unanimity
- Voting results disclosed under Regulation 44 of SEBI Listing Regulations

*this image is generated using AI for illustrative purposes only.
Park Medi World Limited held its 15th Annual General Meeting on September 22, 2026, where shareholders adopted the audited standalone and consolidated financial statements for the fiscal year ended March 31, 2026. The meeting was conducted via Video Conferencing and Other Audio-Visual Means in compliance with regulatory norms.
The proceedings were overseen by Company Secretary and Compliance Officer Abhishek Kapoor, who confirmed the presence of the requisite quorum. A total of 75 shareholders participated in the meeting through virtual means. Dr. Ankit Gupta, Managing Director, was absent due to illness, while Independent Director Dr. Kamlesh Kohli joined from Bhopal.
Key resolutions and voting details
The primary agenda item involved the adoption of the Annual Report for FY26, which includes the Board’s Report and Auditors’ Reports. The statutory records were made available for inspection, and remote e-voting facilities were active from September 18 to September 21, 2026.
Shareholders who did not participate in remote e-voting were allowed to vote during the live session. The final voting results, along with the Scrutinizer’s Report prepared by CS Deepak Sharma of Sharma Jain and Associates, are scheduled to be declared by 5:00 pm on September 23, 2026.
Voting outcomes for all agenda items
All six resolutions proposed at the AGM were passed. While routine items such as financial statement adoption and director reappointment saw overwhelming support, special resolutions regarding the Employee Stock Option Scheme (ESOP) attracted notable dissent from institutional investors.
Ordinary resolutions
Resolution 1: Adoption of audited standalone and consolidated financial statements for FY26. Passed with 99.99% votes in favour.
Resolution 2: Re-appointment of Dr. Sanjay Sharma as Director. Passed with 99.99% votes in favour.
Resolution 3: Ratification of remuneration for Cost Auditor M/s. Sachin Gupta & Co. for FY27. Passed with 99.99% votes in favour.
Resolution 4: Appointment of SBR & Co. LLP as Secretarial Auditors for FY26-FY30. Passed with 99.99% votes in favour.
Special resolutions
Resolution 5: Amendment and ratification of PARK – Employee Stock Option Scheme 2025. Passed with 99.03% votes in favour. Institutional investors cast 12.27% of their polled votes against this resolution.
Resolution 6: Extension of ESOP Scheme 2025 to employees of subsidiary and group companies. Passed with 93.72% votes in favour. This resolution faced the highest opposition, with institutional investors voting 80.03% against it.
Disclosure compliance
The company disseminated this information to BSE and NSE under Regulation 30 of the SEBI (Listing Obligations and Disclosure Requirements) Regulations, 2015. The summary of proceedings is also available on the company’s official website.
| Detail | Information |
|---|---|
| Event | 15th Annual General Meeting |
| Date | September 22, 2026 |
| Mode | Video Conferencing / OAVM |
| Shareholders Present | 75 |
| Results Declaration | By September 23, 2026 |
What the Numbers Show
While the promoter group (holding ~82.9% of shares) voted unanimously in favour of all resolutions, a clear divergence emerged among public institutions regarding the ESOP extensions. For Resolution 6, which extended the ESOP pool to group company employees, institutional investors opposed the move with 80.03% of their votes against, compared to just 12.27% opposition for the general ESOP amendment (Resolution 5). This suggests specific concerns among institutional holders about dilution or governance implications when extending employee benefits beyond the listed entity to its wider group structure.
Historical Stock Returns for Park Medi World
| 1 Day | 5 Days | 1 Month | 6 Months | 1 Year | 5 Years |
|---|---|---|---|---|---|
| +0.14% | +2.08% | +3.84% | +43.15% | +92.70% | +92.70% |
How will Park Medi World address the 80% institutional opposition to extending ESOPs to group companies to prevent future governance conflicts?
What specific dilution impact should minority shareholders anticipate from the approved extension of the ESOP pool to subsidiary employees?
Will the significant dissent from institutional investors trigger a review of the company's current corporate governance framework or board composition?


































